Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation | Zendy

MyungJin Cha | Zendy; EueKeun Choi | Zendy; Kyungdo Han | Zendy; SoRyoung Lee | Zendy; WooHyun Lim | Zendy; Seil Oh | Zendy; Gregory Y.H. Lip | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation

Author(s) -

MyungJin Cha,

EueKeun Choi,

Kyungdo Han,

SoRyoung Lee,

WooHyun Lim,

Seil Oh,

Gregory Y.H. Lip

Publication year - 2017

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.117.018773

Subject(s) - medicine , apixaban , rivaroxaban , warfarin , dabigatran , atrial fibrillation , vitamin k antagonist , stroke (engine) , population , anticoagulant , cardiology , mechanical engineering , environmental health , engineering

There are limited real-world data comparing the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in Asians with nonvalvular atrial fibrillation. We aimed to compare the effectiveness and safety between NOACs and warfarin users in the Korean atrial fibrillation population, with particular focus on high-risk patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research